about
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeAssociation of circulating leptin and adiponectin with periodontitis: a systematic review and meta-analysis.Benefits of healthy adipose tissue in the treatment of diabetes.Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitusTotal and High Molecular Weight Adiponectin Levels and Prediction of Cardiovascular Risk in Diabetic PatientsCigarette Smoking Is Associated with a Lower Prevalence of Newly Diagnosed Diabetes Screened by OGTT than Non-Smoking in Chinese Men with Normal WeightDo circulating blood cell types correlate with modifiable risk factors and outcomes in patients with acute coronary syndrome (ACS)?Adiponectin treatment attenuates inflammatory response during early sepsis in obese mice.Diabetes and ageing-induced vascular inflammation.FGF21 activates AMPK signaling: impact on metabolic regulation and the aging process.Predictive role of adiponectin and high-sensitivity C-reactive protein for prediction of cardiovascular event in an Iranian cohort Study: The Isfahan Cohort Study.Plaque vulnerability at non-culprit lesions in obese patients with coronary artery disease: Frequency-domain optical coherence tomography analysis.Does 8 weeks of strenuous bicycle exercise improve diabetes-related inflammatory cytokines and free fatty acids in type 2 diabetes patients and individuals at high-risk of metabolic syndrome?Association between carotid intima-media thickness and adiponectin in participants without diabetes or cardiovascular disease of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).Relationship Between Adiponectin and apoB in Individuals With Diabetes in the Atlantic PATH Cohort.MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications.
P2860
Q26752744-445E6C62-CB2A-47FE-9E4C-39EC30D6071DQ32174112-2BE9BA7A-D07F-4EA1-9ACC-9639AAE62EFBQ34023537-6898166E-CC57-4B46-8C44-E1272B234BDEQ34256560-3312E86F-48A5-4C16-8154-CB8CC62FE3FDQ35620942-9C9E8872-81EC-4D50-91A1-E54FE823B162Q35949274-9EF52630-445E-43F2-AF26-EC8838757402Q36122935-4B43DAB3-BAE4-4049-8692-19296969766AQ37338105-FBDF180C-557C-4DE5-9222-525BB40AC9C9Q38598866-47A91BA1-8381-4031-B046-B665CE4440DCQ38966510-A59B1005-40CA-437E-BA23-81334139551BQ41370105-D3A6AE18-08FF-4160-B8E6-26EEE246BE56Q50999328-8DBE99AD-32E8-4A2B-A62A-7BBF7881F37EQ51295458-309DC8AA-F234-4CA1-A59E-D6CF0D857C82Q51556568-62762020-6627-4A85-B56B-E8457B7EA4A5Q52398814-1B8C624D-57FA-48FB-91B7-E6584543D685Q54959769-02E14D88-AF7A-416F-B9FE-C7742855FD4F
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Adiponectin, type 2 diabetes and cardiovascular risk.
@en
Adiponectin, type 2 diabetes and cardiovascular risk.
@nl
type
label
Adiponectin, type 2 diabetes and cardiovascular risk.
@en
Adiponectin, type 2 diabetes and cardiovascular risk.
@nl
prefLabel
Adiponectin, type 2 diabetes and cardiovascular risk.
@en
Adiponectin, type 2 diabetes and cardiovascular risk.
@nl
P2093
P2860
P356
P1476
Adiponectin, type 2 diabetes and cardiovascular risk.
@en
P2093
Jan Frystyk
Jan Skov Jensen
Jørgen Jeppesen
Mette Bjerre
Rasmus Mogelvang
Sune H Pedersen
Søren Galatius
Søren Lindberg
P2860
P304
P356
10.1177/2047487313514894
P577
2013-11-21T00:00:00Z